⚕ GalenOps CRO console
← 704 (USA)

704-1010

withdrawn
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 704 (USA) (Dr. Tanaka) · consented 2014-02-21
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-06 (study day 136.0); relationship: NONE

mild assessed 2026-08-18

Mild CONTUSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-06 (study day 136.0); relationship: NONE

mild assessed 2026-08-18

Mild CYSTITIS — outcome: RECOVERED/RESOLVED; onset 2014-02-27 (study day 7.0); relationship: NONE

mild assessed 2026-08-18

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2014-07-05 (study day 135.0); relationship: NONE

mild assessed 2026-08-18

Mild EXCORIATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-06 (study day 136.0); relationship: NONE

mild assessed 2026-08-18

Mild SKIN LACERATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-06 (study day 136.0); relationship: NONE

mild assessed 2026-08-18

Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2014-07-05 (study day 135.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.